Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 118 Pages
Report ld: 3498430
Request Sample
Customized Report
Insulin Injection Consumables Market Size(US$)

CAGR 2025-2031
8%
Market Size,2031
USD 4,293
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Insulin Injection Consumables was estimated to be worth US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
The insulin injection consumables market is witnessing significant growth as a crucial component of diabetes management. These consumables include insulin syringes, pens, and needles used to administer insulin to individuals with diabetes. The market"s expansion is driven by the increasing prevalence of diabetes and the need for effective insulin delivery methods. Insulin injection consumables offer convenience, accuracy, and reduced pain during administration. As diabetes care becomes more personalized and patient-centric, the demand for reliable and user-friendly injection devices is rising. With advancements in design and technology, the insulin injection consumables market is poised to continue growing, contributing to improved quality of life for individuals managing diabetes.
This report aims to provide a comprehensive presentation of the global market for Insulin Injection Consumables, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insulin Injection Consumables by region & country, by Type, and by Application.
The Insulin Injection Consumables market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Injection Consumables.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insulin Injection Consumables manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insulin Injection Consumables in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insulin Injection Consumables in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Insulin Injection Consumables Product Introduction
1.2 Global Insulin Injection Consumables Market Size Forecast
1.2.1 Global Insulin Injection Consumables Sales Value (2020-2031)
1.2.2 Global Insulin Injection Consumables Sales Volume (2020-2031)
1.2.3 Global Insulin Injection Consumables Sales Price (2020-2031)
1.3 Insulin Injection Consumables Market Trends & Drivers
1.3.1 Insulin Injection Consumables Industry Trends
1.3.2 Insulin Injection Consumables Market Drivers & Opportunity
1.3.3 Insulin Injection Consumables Market Challenges
1.3.4 Insulin Injection Consumables Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insulin Injection Consumables Players Revenue Ranking (2024)
2.2 Global Insulin Injection Consumables Revenue by Company (2020-2025)
2.3 Global Insulin Injection Consumables Players Sales Volume Ranking (2024)
2.4 Global Insulin Injection Consumables Sales Volume by Company Players (2020-2025)
2.5 Global Insulin Injection Consumables Average Price by Company (2020-2025)
2.6 Key Manufacturers Insulin Injection Consumables Manufacturing Base and Headquarters
2.7 Key Manufacturers Insulin Injection Consumables Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insulin Injection Consumables
2.9 Insulin Injection Consumables Market Competitive Analysis
2.9.1 Insulin Injection Consumables Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Insulin Injection Consumables Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insulin Injection Consumables as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Insulin Injection Pen
3.1.2 Insulin Injection Needle
3.2 Global Insulin Injection Consumables Sales Value by Type
3.2.1 Global Insulin Injection Consumables Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Insulin Injection Consumables Sales Value, by Type (2020-2031)
3.2.3 Global Insulin Injection Consumables Sales Value, by Type (%) (2020-2031)
3.3 Global Insulin Injection Consumables Sales Volume by Type
3.3.1 Global Insulin Injection Consumables Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Insulin Injection Consumables Sales Volume, by Type (2020-2031)
3.3.3 Global Insulin Injection Consumables Sales Volume, by Type (%) (2020-2031)
3.4 Global Insulin Injection Consumables Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Home
4.1.3 Others
4.2 Global Insulin Injection Consumables Sales Value by Application
4.2.1 Global Insulin Injection Consumables Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Insulin Injection Consumables Sales Value, by Application (2020-2031)
4.2.3 Global Insulin Injection Consumables Sales Value, by Application (%) (2020-2031)
4.3 Global Insulin Injection Consumables Sales Volume by Application
4.3.1 Global Insulin Injection Consumables Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Insulin Injection Consumables Sales Volume, by Application (2020-2031)
4.3.3 Global Insulin Injection Consumables Sales Volume, by Application (%) (2020-2031)
4.4 Global Insulin Injection Consumables Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Insulin Injection Consumables Sales Value by Region
5.1.1 Global Insulin Injection Consumables Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Insulin Injection Consumables Sales Value by Region (2020-2025)
5.1.3 Global Insulin Injection Consumables Sales Value by Region (2026-2031)
5.1.4 Global Insulin Injection Consumables Sales Value by Region (%), (2020-2031)
5.2 Global Insulin Injection Consumables Sales Volume by Region
5.2.1 Global Insulin Injection Consumables Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Insulin Injection Consumables Sales Volume by Region (2020-2025)
5.2.3 Global Insulin Injection Consumables Sales Volume by Region (2026-2031)
5.2.4 Global Insulin Injection Consumables Sales Volume by Region (%), (2020-2031)
5.3 Global Insulin Injection Consumables Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Insulin Injection Consumables Sales Value, 2020-2031
5.4.2 North America Insulin Injection Consumables Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Insulin Injection Consumables Sales Value, 2020-2031
5.5.2 Europe Insulin Injection Consumables Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Insulin Injection Consumables Sales Value, 2020-2031
5.6.2 Asia Pacific Insulin Injection Consumables Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Insulin Injection Consumables Sales Value, 2020-2031
5.7.2 South America Insulin Injection Consumables Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insulin Injection Consumables Sales Value, 2020-2031
5.8.2 Middle East & Africa Insulin Injection Consumables Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insulin Injection Consumables Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Insulin Injection Consumables Sales Value
6.2.1 Key Countries/Regions Insulin Injection Consumables Sales Value, 2020-2031
6.2.2 Key Countries/Regions Insulin Injection Consumables Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Insulin Injection Consumables Sales Value, 2020-2031
6.3.2 United States Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Insulin Injection Consumables Sales Value, 2020-2031
6.4.2 Europe Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Insulin Injection Consumables Sales Value, 2020-2031
6.5.2 China Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.5.3 China Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Insulin Injection Consumables Sales Value, 2020-2031
6.6.2 Japan Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Insulin Injection Consumables Sales Value, 2020-2031
6.7.2 South Korea Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Insulin Injection Consumables Sales Value, 2020-2031
6.8.2 Southeast Asia Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Insulin Injection Consumables Sales Value, 2020-2031
6.9.2 India Insulin Injection Consumables Sales Value by Type (%), 2024 VS 2031
6.9.3 India Insulin Injection Consumables Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 BD
7.1.1 BD Company Information
7.1.2 BD Introduction and Business Overview
7.1.3 BD Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 BD Insulin Injection Consumables Product Offerings
7.1.5 BD Recent Development
7.2 Novo Nordisk
7.2.1 Novo Nordisk Company Information
7.2.2 Novo Nordisk Introduction and Business Overview
7.2.3 Novo Nordisk Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Novo Nordisk Insulin Injection Consumables Product Offerings
7.2.5 Novo Nordisk Recent Development
7.3 Artsana
7.3.1 Artsana Company Information
7.3.2 Artsana Introduction and Business Overview
7.3.3 Artsana Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Artsana Insulin Injection Consumables Product Offerings
7.3.5 Artsana Recent Development
7.4 B. Braun
7.4.1 B. Braun Company Information
7.4.2 B. Braun Introduction and Business Overview
7.4.3 B. Braun Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 B. Braun Insulin Injection Consumables Product Offerings
7.4.5 B. Braun Recent Development
7.5 Terumo
7.5.1 Terumo Company Information
7.5.2 Terumo Introduction and Business Overview
7.5.3 Terumo Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Terumo Insulin Injection Consumables Product Offerings
7.5.5 Terumo Recent Development
7.6 Ypsomed Holding
7.6.1 Ypsomed Holding Company Information
7.6.2 Ypsomed Holding Introduction and Business Overview
7.6.3 Ypsomed Holding Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Ypsomed Holding Insulin Injection Consumables Product Offerings
7.6.5 Ypsomed Holding Recent Development
7.7 Owen Mumford
7.7.1 Owen Mumford Company Information
7.7.2 Owen Mumford Introduction and Business Overview
7.7.3 Owen Mumford Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Owen Mumford Insulin Injection Consumables Product Offerings
7.7.5 Owen Mumford Recent Development
7.8 HTL-Strefa
7.8.1 HTL-Strefa Company Information
7.8.2 HTL-Strefa Introduction and Business Overview
7.8.3 HTL-Strefa Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 HTL-Strefa Insulin Injection Consumables Product Offerings
7.8.5 HTL-Strefa Recent Development
7.9 Beipu
7.9.1 Beipu Company Information
7.9.2 Beipu Introduction and Business Overview
7.9.3 Beipu Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Beipu Insulin Injection Consumables Product Offerings
7.9.5 Beipu Recent Development
7.10 Kangdelai
7.10.1 Kangdelai Company Information
7.10.2 Kangdelai Introduction and Business Overview
7.10.3 Kangdelai Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Kangdelai Insulin Injection Consumables Product Offerings
7.10.5 Kangdelai Recent Development
7.11 Ulticare
7.11.1 Ulticare Company Information
7.11.2 Ulticare Introduction and Business Overview
7.11.3 Ulticare Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Ulticare Insulin Injection Consumables Product Offerings
7.11.5 Ulticare Recent Development
7.12 Allison Medical
7.12.1 Allison Medical Company Information
7.12.2 Allison Medical Introduction and Business Overview
7.12.3 Allison Medical Insulin Injection Consumables Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Allison Medical Insulin Injection Consumables Product Offerings
7.12.5 Allison Medical Recent Development
8 Industry Chain Analysis
8.1 Insulin Injection Consumables Industrial Chain
8.2 Insulin Injection Consumables Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insulin Injection Consumables Sales Model
8.5.2 Sales Channel
8.5.3 Insulin Injection Consumables Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 120
USD 2900.00
(Single User License)
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 95
USD 4250.00
(Single User License)
The global Insulin Injection Consumables market is projected to grow from US$ 2523 million in 2024 to US$ 4293 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 170
USD 4900.00
(Single User License)
The global market for Insulin Injection Consumables was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 4293 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published Date: 2025-01-13
Pages: 97
USD 2900.00
(Single User License)
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-04-15
Pages: 108
USD 4900.00
(Single User License)
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published Date: 2024-01-17
Pages: 88
USD 2900.00
(Single User License)
The global market for Insulin Injection Consumables was estimated to be worth US$ 2705 million in 2025 and is projected to reach US$ 4602 million, growing at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Insulin Injection Consumables market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 4602 million by 2032, at a CAGR of 8.0% from 2026 to 2032.
Published: 2026-04-17
Pages: 120
The global Insulin Injection Consumables market size was US$ 2523 million in 2024 and is forecast to a readjusted size of US$ 4293 million by 2031 with a CAGR of 8.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 95
The global Insulin Injection Consumables market is projected to grow from US$ 2523 million in 2024 to US$ 4293 million by 2031, at a CAGR of 8.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 170
The global market for Insulin Injection Consumables was valued at US$ 2523 million in the year 2024 and is projected to reach a revised size of US$ 4293 million by 2031, growing at a CAGR of 8.0% during the forecast period.
Published: 2025-01-13
Pages: 97
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-04-15
Pages: 108
Insulin Injection Related Product are used in conjunction with injection pens to deliver injectable medications into the body.
Published: 2024-01-17
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now